KATRINA HOCH, KRISTEN CARLIN, ALISSA ROBERTS, BRYAN STRUB, ELAINE WALSH
{"title":"2093-P: HbA1c Trajectories and Risk of Impaired Glucose in Adolescents with Polycystic Ovarian Syndrome","authors":"KATRINA HOCH, KRISTEN CARLIN, ALISSA ROBERTS, BRYAN STRUB, ELAINE WALSH","doi":"10.2337/db26-2093-p","DOIUrl":null,"url":null,"abstract":"Introduction and Objective: Polycystic Ovarian Syndrome (PCOS) affects up to 12% of women of reproductive age and is associated with increased risk of insulin resistance and impaired glucose tolerance. This study evaluated baseline HbA1c levels and longitudinal HbA1c trajectories in adolescents with PCOS to identify characteristics associated with elevated or increasing HbA1c and to inform opportunities for enhanced screening and support. Methods: This retrospective cohort study used electronic health records from a free-standing pediatric hospital (January 2016-July 2025). Patients with a confirmed diagnosis of PCOS were included. Longitudinal HbA1c trajectories were evaluated using linear mixed-effects models with random intercepts and slopes, examining the impact of key demographic and clinical characteristics. Results: A total of 819 patients met inclusion criteria, with 0-7.2 years of follow-up. Mean HbA1c (5.4) across the population remained stable, but several factors were associated with increased HbA1c throughout the study period, including higher BMI (β=0.06, 95% CI=0.03, 0.09), older age at PCOS diagnosis (β=0.03, 95% CI=0.00, 0.05), Asian or unknown/declined race (β=0.18, 95% CI=0.05, 0.31 and β=0.25, 95% CI=0.04, 0.46, respectively) and acanthosis (β=0.18, 95% CI = 0.07, 0.28). Ethnicity moderated trajectories: HbA1c declined over time in non-Hispanic patients and increased in Hispanic patients (β=0.12, 95% CI=0.05, 0.20). Language also moderated patterns, with those with a language of care (LOC) of Spanish showing decreasing HbA1c relative to English and other LOC (β=-0.13, 95% CI=-0.23, -0.02). Conclusion: Early PCOS identification may help prevent rising HbA1c in higher-risk groups, including adolescents identifying as Asian or unknown/declined race. Patients from some groups may benefit from continued support after diagnosis. Language patterns suggest that culturally and linguistically aligned care may be protective for some patients. Disclosure K. Hoch: None. K. Carlin: None. A. Roberts: None. B. Strub: None. E. Walsh: None. Funding Lenssen Grant for Nutrition Research at Seattle Children's Research Institute","PeriodicalId":11376,"journal":{"name":"Diabetes","volume":"46 1","pages":""},"PeriodicalIF":9.3000,"publicationDate":"2026-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2337/db26-2093-p","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction and Objective: Polycystic Ovarian Syndrome (PCOS) affects up to 12% of women of reproductive age and is associated with increased risk of insulin resistance and impaired glucose tolerance. This study evaluated baseline HbA1c levels and longitudinal HbA1c trajectories in adolescents with PCOS to identify characteristics associated with elevated or increasing HbA1c and to inform opportunities for enhanced screening and support. Methods: This retrospective cohort study used electronic health records from a free-standing pediatric hospital (January 2016-July 2025). Patients with a confirmed diagnosis of PCOS were included. Longitudinal HbA1c trajectories were evaluated using linear mixed-effects models with random intercepts and slopes, examining the impact of key demographic and clinical characteristics. Results: A total of 819 patients met inclusion criteria, with 0-7.2 years of follow-up. Mean HbA1c (5.4) across the population remained stable, but several factors were associated with increased HbA1c throughout the study period, including higher BMI (β=0.06, 95% CI=0.03, 0.09), older age at PCOS diagnosis (β=0.03, 95% CI=0.00, 0.05), Asian or unknown/declined race (β=0.18, 95% CI=0.05, 0.31 and β=0.25, 95% CI=0.04, 0.46, respectively) and acanthosis (β=0.18, 95% CI = 0.07, 0.28). Ethnicity moderated trajectories: HbA1c declined over time in non-Hispanic patients and increased in Hispanic patients (β=0.12, 95% CI=0.05, 0.20). Language also moderated patterns, with those with a language of care (LOC) of Spanish showing decreasing HbA1c relative to English and other LOC (β=-0.13, 95% CI=-0.23, -0.02). Conclusion: Early PCOS identification may help prevent rising HbA1c in higher-risk groups, including adolescents identifying as Asian or unknown/declined race. Patients from some groups may benefit from continued support after diagnosis. Language patterns suggest that culturally and linguistically aligned care may be protective for some patients. Disclosure K. Hoch: None. K. Carlin: None. A. Roberts: None. B. Strub: None. E. Walsh: None. Funding Lenssen Grant for Nutrition Research at Seattle Children's Research Institute
期刊介绍:
Diabetes is a scientific journal that publishes original research exploring the physiological and pathophysiological aspects of diabetes mellitus. We encourage submissions of manuscripts pertaining to laboratory, animal, or human research, covering a wide range of topics. Our primary focus is on investigative reports investigating various aspects such as the development and progression of diabetes, along with its associated complications. We also welcome studies delving into normal and pathological pancreatic islet function and intermediary metabolism, as well as exploring the mechanisms of drug and hormone action from a pharmacological perspective. Additionally, we encourage submissions that delve into the biochemical and molecular aspects of both normal and abnormal biological processes.
However, it is important to note that we do not publish studies relating to diabetes education or the application of accepted therapeutic and diagnostic approaches to patients with diabetes mellitus. Our aim is to provide a platform for research that contributes to advancing our understanding of the underlying mechanisms and processes of diabetes.